ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 215 filers reported holding ARRAY BIOPHARMA INC in Q3 2018. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $60,000 | +87.5% | 1,300 | 0.0% | 0.01% | -25.0% |
Q1 2019 | $32,000 | +68.4% | 1,300 | 0.0% | 0.01% | +100.0% |
Q4 2018 | $19,000 | -5.0% | 1,300 | 0.0% | 0.00% | -55.6% |
Q3 2018 | $20,000 | +11.1% | 1,300 | -12.8% | 0.01% | +80.0% |
Q3 2017 | $18,000 | -99.8% | 1,490 | +19.2% | 0.01% | +150.0% |
Q4 2016 | $11,000,000 | +137400.0% | 1,250 | 0.0% | 0.00% | +100.0% |
Q3 2016 | $8,000 | – | 1,250 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Redmile Group, LLC | 16,459,128 | $234,543,000 | 9.43% |
APIS CAPITAL ADVISORS, LLC | 490,000 | $6,983,000 | 9.36% |
BVF INC/IL | 4,744,062 | $67,603,000 | 8.84% |
First Light Asset Management, LLC | 2,853,826 | $40,667,000 | 6.48% |
SECTORAL ASSET MANAGEMENT INC | 2,165,767 | $30,862,000 | 4.20% |
GREAT POINT PARTNERS LLC | 1,850,000 | $26,363,000 | 3.33% |
PACIFIC VIEW ASSET MANAGEMENT, LLC | 146,952 | $2,092,000 | 2.46% |
Birchview Capital, LP | 168,000 | $2,394,000 | 2.26% |
X-Square Capital, LLC | 180,554 | $2,572,000 | 2.02% |
FINANCIAL & INVESTMENT MANAGEMENT GROUP LTD | 295,610 | $4,212,000 | 1.54% |